![Max Rosett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Max Rosett
Directeur Financier/CFO chez
IMMUNOME, INC.
Fortune : 2 M $ au 31/07/2026
Profil
Max Rosett currently works at Immunome, Inc. as CFO, Chief Accounting Officer & EVP-Operations since 2024.
Formerly, Mr. Rosett was Chief Operating Officer at MorphImmune, Inc. from 2022 to 2023 and Principal at Research Bridge Partners from 2021 to 2023.
Mr. Rosett completed graduate education at Georgia Institute of Technology in 2016 and undergraduate education at Yale University in 2012.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNOME, INC. 0,09 % | 23/07/2026 | 101 287 ( 0,09 % ) | 2 M $ | 31/07/2026 |
Postes actifs de Max Rosett
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOME, INC. | Directeur Financier/CFO | 02/01/2024 |
Anciens postes connus de Max Rosett
| Sociétés | Poste | Fin |
|---|---|---|
Research Bridge Partners /Venture Capital/
 Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Corporate Officer/Principal | 01/11/2023 |
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Directeur des opérations | 01/10/2023 |
Formation de Max Rosett
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Finance |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
